The course is mainly aimed at graduates in biomedical, bioengineering, bioinformatics, chemistry and physics disciplines. Those who have obtained a second level degree (or equivalent foreign qualification) and with good knowledge of the English language (spoken and written) can apply for admission.
The course lasts three years, during which the training of doctoral students takes place through direct participation in clinical or experimental research projects of high scientific value, which use the most advanced methodologies and instruments. The research activities take place in the laboratories of the IRFMN in Milan, Bergamo or Ranica. The course, recently accredited by the MUR, expands the higher education offer proposed by the IRFMN.
The Course aims to train young professionals by providing a solid cultural and methodological background in the field of clinical and experimental pharmacology. This will enable future researchers to translate the theoretical skills acquired into effective professional and managerial skills and provide them with job opportunities in public and private, domestic and foreign research laboratories, in the structures of the National Health System, in the centers for the development of pharmaceutical and diagnostic products, in the pharmaceutical, agri-food, diagnostics industries (in biomedicine, research and quality control).
Admission to the course is governed by calls published annually on the IRFMN, MUR and Euraxess websites. The admission exam includes the evaluation of qualifications and an interview for the evaluation of logical, scientific and linguistic knowledge (English).
Applications for admission to the selection, accompanied by the required documentation, must be submitted through the online form. Before filling out the form, carefully read the call, specifically the bold text.
An additional PhD position of the Clinical and Experimental Pharmacology Course is available (See Annex 1, Project #16).